Fiduciary Trust’s Revolution Medicines RVMD Stock Holding History

Fiduciary Trust’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.74M	Sell	17,898 -5,200	-23%	-$525K	0.02%	305
2025 Q4	$1.84M	Buy	23,098 +3	+0%	+$197	0.02%	295
2025 Q3	$1.08M	Hold	23,095	–	–	0.01%	400
2025 Q2	$850K	Hold	23,095	–	–	0.01%	432
2025 Q1	$817K	Hold	23,095	–	–	0.01%	426
2024 Q4	$1.01M	Hold	23,095	–	–	0.01%	354
2024 Q3	$1.05M	Hold	23,095	–	–	0.01%	354
2024 Q2	$896K	Hold	23,095	–	–	0.01%	358
2024 Q1	$744K	Hold	23,095	–	–	0.01%	394
2023 Q4	$662K	Hold	23,095	–	–	0.01%	398
2023 Q3	$639K	Hold	23,095	–	–	0.01%	389
2023 Q2	$618K	Hold	23,095	–	–	0.01%	407
2023 Q1	$500K	Buy	23,095 +4,629	+25%	+$114K	0.01%	437
2022 Q4	$440K	Buy	18,466 +4,679	+34%	+$99.5K	0.01%	474
2022 Q3	$272K	Buy	+13,787	New	+$303K	0.01%	540
2022 Q2	–	Sell	-9,888	Closed	-$252K	–	664
2022 Q1	$252K	Hold	9,888	–	–	﹤0.01%	593
2021 Q4	$249K	Hold	9,888	–	–	﹤0.01%	599
2021 Q3	$272K	Hold	9,888	–	–	﹤0.01%	580
2021 Q2	$314K	Hold	9,888	–	–	0.01%	546
2021 Q1	$454K	Buy	+9,888	New	+$443K	0.01%	471

Other funds holding RVMD

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fiduciary Trust's RVMD Position: Q1 2026 in Review

Fiduciary Trust reduced its Revolution Medicines (RVMD) stake by 23% in Q1 2026, selling an estimated $525K and leaving 17,898 shares worth $1.74M. The position accounts for 0.02% of the portfolio, ranked #305.

Fiduciary Trust first reported a position in RVMD in Q1 2021 and has held it in 20 quarters since. The position peaked at $1.84M in Q4 2025. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

Fiduciary Trust held 17,898 shares of Revolution Medicines worth $1.74M as of Q1 2026.
Fiduciary Trust sold 5,200 Revolution Medicines shares in Q1 2026, an estimated $525K.
Revolution Medicines made up 0.02% of Fiduciary Trust's portfolio in Q1 2026, its #305 holding.
Fiduciary Trust first reported a position in Revolution Medicines in Q1 2021 and has held it in 20 quarters since.
Fiduciary Trust's Revolution Medicines position peaked at $1.84M in Q4 2025.
512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Fiduciary Trust's 13F filing for Q1 2026, filed 15 May 2026.